由于质量问题,Zydus和AvKARE召回胆固醇药物;没有报告严重危害。 Zydus and AvKARE recall cholesterol drugs due to quality issues; no serious harm reported.

Zydus制药公司和AvKARE公司因质量问题召回了数千瓶胆固醇药物。 Zydus Pharmaceuticals and AvKARE are recalling thousands of bottles of cholesterol medications due to quality issues. 由于漏和氧化囊的潜在效果,Zydus正在召回Icosapent乙烯囊,而AvKARE正在召回无法正常溶解的罗斯瓦斯塔丁片. Zydus is recalling Icosapent Ethyl capsules due to subpotency from leaking and oxidized capsules, while AvKARE is recalling Rosuvastatin Tablets that fail to dissolve properly. 两次召回均被FDA归类为II类,表明暂时或可逆健康问题的风险较低. Both recalls are classified as Class II by the FDA, indicating a low risk of temporary or reversible health issues. 没有关于严重影响的报告,但敦促病人检查其药物,并就替代方法咨询保健服务提供者。 No serious effects have been reported, but patients are urged to check their medications and consult healthcare providers about alternatives.